title: Exposure of personnel and public due to using 153Sm-labelled EDTMP-Quadramet® in nuclear medicine procedures.
abstract: The main aim of this study was to highlight the problems of personnel exposure when administering (153)Sm-labelled ethylene diamine tetramethylene phosphonate-Quadramet(®) to patients and especially to evaluate hand exposure of the personnel. The exposure levels of patients' families and the people who takes care of the patients treated by Quadramet(®) were also estimated. Thermoluminescent detectors were used to measure the doses. The doses received during the injection of the Quadramet(®) by the nursing staff have been determined at the level of 1/150 dose limit for the skin. Exposure of members of the patient's family staying 1.5 m away from the patient being treated with Quadramet(®) has been estimated to be 0.40 mGy.
authors.affiliation: Department of Nuclear Physics and Radiation Safety, Faculty of Physics and Applied Informatics, University of Lodz, Pomorska 149/153, Lodz 90-236, Poland mwrzesien@uni.lodz.pl.
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Wrzesień
authors.affiliation: PET/CT Laboratory, Medical Diagnostic Centre VOXEL, Polnocna 42, Lodz 91-425, Poland.
authors.forename: Katarzyna
authors.initials: K
authors.lastname: Napolska
authors.affiliation: Department of Radiation Protection, Nofer Institute of Occupational Medicine, Teresy 8, Lodz 91-348, Poland.
authors.forename: Jerzy
authors.initials: J
authors.lastname: Olszewski
mesh_terms: D018712:Analgesics, Non-Narcotic; D005190:Family; D006801:Humans; D009369:Neoplasms / Q000000981:diagnostic imaging*; D009683:Nuclear Medicine; D009726:Nurses / Q000706:statistics & numerical data; D016273:Occupational Exposure / Q000009:adverse effects*; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D011829:Radiation Dosage; D000069079:Radiation Exposure / Q000032:analysis*; D019275:Radiopharmaceuticals; D013819:Thermoluminescent Dosimetry
chemical_list: D018712:Analgesics, Non-Narcotic; D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D019275:Radiopharmaceuticals; C061972:samarium Sm-153 lexidronam